Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15Leukemia, Myeloid, Chronic-Phase 6Neoplasm Metastasis 4Neoplasms 3Philadelphia Chromosome 2Ovarian Neoplasms 2Myeloproliferative Disorders 2Leukemia 2Synovitis, Pigmented Villonodular 1Sarcoma 1Recurrence 1Peritoneal Neoplasms 1Neoplasm, Residual 1Melanoma 1Leukemia, Myeloid 1Hematologic Diseases 1Giant Cell Tumor of Tendon Sheath 1Genital Neoplasms, Female 1Gastrointestinal Stromal Tumors 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Chordoma 1Cholangiocarcinoma 1Breast Neoplasms 1Blast Crisis 1Appendiceal Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Mitomycin 6Leucovorin 4Fluorouracil 4Oxaliplatin 3dehydroftorafur 2Mitozytrex 2Irinotecan 2Hyperthermic Intraperitoneal Chemotherapy 2Doxorubicin 2Cisplatin 2Biopsy 2surufatinib 1sodium thiosulfate 1sintilimab 1nilotinib 1irinotecan sucrosofate 1Surveys and Questionnaires 1Specimen Handling 1Platinum 1Pafolacianine 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Laparoscopy 1Immunoglobulin G 1Floxuridine 1Electrocardiography 1Disulfides 1Cytoreduction Surgical Procedures 1Cryotherapy 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Appendiceal Neoplasms × nilotinib × 1 year × Clear all
NCT05185947 2026-05-29

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
21 enrolled 21 charts
BreastGastrointestinalGynecologic

Appendiceal Neoplasms, Breast Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡